iBio
IBIO
IBIO
43 hedge funds and large institutions have $4.97M invested in iBio in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
43
Holding in Top 10
–
Calls
$85K
Puts
$73K
Top Buyers
| 1 | +$782K | |
| 2 | +$228K | |
| 3 | +$53.1K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$49.8K |
| 5 |
Renaissance Technologies
New York
|
+$37.6K |
Top Sellers
| 1 | -$602K | |
| 2 | -$141K | |
| 3 | -$78K | |
| 4 |
Morgan Stanley
New York
|
-$74.9K |
| 5 |
E
Ergoteles
New York
|
-$53.3K |